These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 9829022

  • 1. Role of serotonin in obsessive-compulsive disorder.
    Baumgarten HG, Grozdanovic Z.
    Br J Psychiatry Suppl; 1998; (35):13-20. PubMed ID: 9829022
    [Abstract] [Full Text] [Related]

  • 2. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [Abstract] [Full Text] [Related]

  • 3. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 4. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B, Bonnet-Perrin E.
    Encephale; 2001 Dec; 27(3):280-9. PubMed ID: 11488259
    [Abstract] [Full Text] [Related]

  • 5. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT, Insel TR.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [Abstract] [Full Text] [Related]

  • 6. Issues in the monopharmacotherapy and polypharmacotherapy of obsessive-compulsive disorder.
    Laird LK.
    Psychopharmacol Bull; 1996 Aug; 32(4):569-78. PubMed ID: 8993077
    [Abstract] [Full Text] [Related]

  • 7. Changes in cerebrospinal fluid neurochemistry during treatment of obsessive-compulsive disorder with clomipramine.
    Altemus M, Swedo SE, Leonard HL, Richter D, Rubinow DR, Potter WZ, Rapoport JL.
    Arch Gen Psychiatry; 1994 Oct; 51(10):794-803. PubMed ID: 7524463
    [Abstract] [Full Text] [Related]

  • 8. Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology.
    Zohar J, Insel TR.
    Biol Psychiatry; 1987 Jun; 22(6):667-87. PubMed ID: 3036259
    [Abstract] [Full Text] [Related]

  • 9. Obsessive-compulsive disorder in children and adolescents.
    Riddle M.
    Br J Psychiatry Suppl; 1998 Jun; (35):91-6. PubMed ID: 9829031
    [Abstract] [Full Text] [Related]

  • 10. Effectiveness of paroxetine in the treatment of obsessive-compulsive disorders.
    Kamijima K, Aoki M.
    Expert Rev Neurother; 2006 Jul; 6(7):945-56. PubMed ID: 16831110
    [Abstract] [Full Text] [Related]

  • 11. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S, Harvey BH.
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [Abstract] [Full Text] [Related]

  • 12. Transmission disequilibrium analysis of the functional 5-HT3A receptor variant C178T in early-onset obsessive compulsive-disorder.
    Mössner R, Döring N, Scherag A, Schäfer H, Herpertz-Dahlmann B, Remschmidt H, Schulz E, Renner T, Wewetzer C, Warnke A, Lesch KP, Walitza S.
    J Psychopharmacol; 2007 Nov; 21(8):833-6. PubMed ID: 17259209
    [Abstract] [Full Text] [Related]

  • 13. [Role of the neurohypophysis in psychological stress].
    Scantamburlo G, Ansseau M, Legros JJ.
    Encephale; 2001 Nov; 27(3):245-59. PubMed ID: 11488255
    [Abstract] [Full Text] [Related]

  • 14. Possible role of neuropeptides in obsessive compulsive disorder.
    McDougle CJ, Barr LC, Goodman WK, Price LH.
    Psychoneuroendocrinology; 1999 Jan; 24(1):1-24. PubMed ID: 10098217
    [Abstract] [Full Text] [Related]

  • 15. The combined effects of memantine and fluoxetine on an animal model of obsessive compulsive disorder.
    Wald R, Dodman N, Shuster L.
    Exp Clin Psychopharmacol; 2009 Jun; 17(3):191-7. PubMed ID: 19586234
    [Abstract] [Full Text] [Related]

  • 16. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS, Westenberg HG.
    J Psychiatr Res; 2008 Sep; 42(11):894-901. PubMed ID: 18533183
    [Abstract] [Full Text] [Related]

  • 17. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome.
    Perugi G, Toni C, Frare F, Travierso MC, Hantouche E, Akiskal HS.
    J Clin Psychiatry; 2002 Dec; 63(12):1129-34. PubMed ID: 12523872
    [Abstract] [Full Text] [Related]

  • 18. Treatment of obsessive-compulsive spectrum disorders with SSRIs.
    Hollander E.
    Br J Psychiatry Suppl; 1998 Dec; (35):7-12. PubMed ID: 9829021
    [Abstract] [Full Text] [Related]

  • 19. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA, DeMeo MD, Sweeney JA, Halper J, Mann JJ, Shear MK.
    Biol Psychiatry; 1992 Jan 01; 31(1):19-34. PubMed ID: 1311964
    [Abstract] [Full Text] [Related]

  • 20. [Drug treatment of obsessive-compulsive disorder. With proper drugs and some patience many patients can be helped].
    Mavrogiorgou P, Hegerl U.
    MMW Fortschr Med; 1999 Sep 30; 141(39):32-4, 37. PubMed ID: 10897982
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.